Eave Tubes were designed and developed by In2Care in 2012, based on our patented static netting technology, which has been shown to improve insecticide bioavailability and successfully kill even insecticide-resistant malaria vectors.
Eave Tube efficacy against malaria mosquitoes was validated by multiple research partners under the EU-FP7-funded MCD Project between 2013 and 2015. Our Introduction paper published in the Malaria Journal describes the Eave Tube concept and the MCD Project objectives in more detail. Several studies were executed in Tanzania and Kenya under semi-field and field conditions, and results confirmed the high potential for Eave Tubes to effectively kill malaria vectors. Tanzania semi-field results, Modeling results, Kenya semi-field results and videogaphic study results were all published in peer-reviewed academic journals.
We executed a Demonstration Pilot in the Tanzanian village Mngeta in 2014 and 2015, where 1800 houses received Eave Tubes. This showed that Eave Tubes can be successfully implemented in remote rural areas. 92% of participants reported to be satisfied with the product and perceived a reduction in mosquito nuisance. Results showed that the risk of indoor infectious mosquito bites can be reduced with >90% when covering only 70% of all houses with Eave Tubes.
In collaboration with the Human Development Innovation Fund (HDIF) Tanzania and our local research partner the Ifakara Health Institute, a large-scale field evaluation of Eave Tubes was carried out in Tanzania in 2016 & 2017. In total, 1,500 houses in the Dar es Salaam and Morogoro regions received In2Care Eave Tubes. See video below.
Based on these promising outcomes, Eave Tubes are now being evaluated in a large epidemiological field trial in Ivory Coast.